EUVIMEDEUVIMED entdecken
Crossref

The glucose monitoring comparison in primary care study (GluCoCare): Study design, methods, recruitment success, and baseline characteristics of study participants

Thomas W Martens, Stephen E Asche, Meghan M JaKa, Mary L Johnson, Sean Dunnigan, Alyse L Haven, Colette Morris, David Barnaby, Michael V Maciosek, Jennifer M Dinh, Samantha J Kaiser, Nicole K Trower und 7 weitere

Contemporary Clinical Trials · 2026-07 · 166 · 108357

DOI: 10.1016/j.cct.2026.108357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2026-07. Verfasst von Thomas W Martens und 18 weiteren Autor:innen. Beteiligte Einrichtung: International Diabetes Center, HealthPartners Institute, 3800 Park Nicollet Blvd., Suite 600, Minneapolis, MN, United States of America; Department o…. Hauptthemen laut MEDLINE: Blood Glucose Self-Monitoring, Continuous Glucose Monitoring, Diabetes Mellitus, Type 2, Hypoglycemic Agents. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Patient-Centered Outcomes Research Institute, Stanford Diabetes Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: While both fingerstick blood glucose monitoring (BGM) and continuous glucose monitoring (CGM) are currently available for people managing type 2 diabetes (T2D) with insulin, it is not currently known which is more effective in optimizing glycemia and decreasing disease burden in this population in real-world settings. OBJECTIVES: This two-arm cluster-randomized trial will compare use of BGM versus CGM in individuals with T2D using insulin not meeting A1C goals. We will compare change in hemoglobin A1c (A1C) (primary outcome measure) and Diabetes Distress Scale score (DDS) (secondary outcome measure) in individuals attending primary care clinics randomized to either BGM or CGM monitoring over 12 months. MATERIALS AND METHODS: Fifty clinics in a large healthcare system in Minnesota and Wisconsin were randomized to enroll individuals to monitor with BGM (25 clinics) or CGM (25 clinics). Adults aged 18-75 with T2D using insulin, A1C 7.5-12%, were recruited from these clinics to be managed by their primary care clinician in a fundamentally pragmatic intervention over 12 months. A1C, DDS, and blinded CGM along with patient reported outcome (PRO) measures will be compared between 0 and 12 months. RESULTS: GluCoCare met its enrollment goals, enrolling 360 individuals from 42 primary care clinics between September 2022 and June 2024, age (mean ± SD) 60.5 ± 10.3 years, diabetes duration 14.3 ± 8.2 years, A1C 8.8% ± 1.1%, and DDS 2.2 ± 0.9. CONCLUSIONS: We have successfully enrolled participants with T2D using insulin, to test in a real-world primary care setting, whether BGM versus CGM improves A1c or decreases Diabetes Distress Scale score more.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Glucose Self-MonitoringContinuous Glucose MonitoringDiabetes Mellitus, Type 2Hypoglycemic AgentsInsulinAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultBlood GlucoseGlycated HemoglobinMinnesotaMulticenter Studies as TopicPatient SelectionPragmatic Clinical Trials as TopicPrimary Health CareRandomized Controlled Trials as TopicResearch DesignWisconsin

Stichwörter der Autor:innen

Blood glucose monitorContinuous glucose monitorPrimary careType 2 diabetes

Substanzen

Blood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • International Diabetes Center, HealthPartners Institute, 3800 Park Nicollet Blvd., Suite 600, Minneapolis, MN, United States of America; Department of Internal Medicine, Park Nicollet Clinic Brooklyn Center-Brookdale Of…
  • HealthPartners Institute, 8170 33rd Ave S., Bloomington, MN, United States of America.
  • Center for Evaluation and Survey Research, HealthPartners Institute, 8170 33rd Ave S., Bloomington, MN, United States of America.
  • International Diabetes Center, HealthPartners Institute, 3800 Park Nicollet Blvd., Suite 600, Minneapolis, MN, United States of America.

Förderung

  • Patient-Centered Outcomes Research Institute
  • Stanford Diabetes Research Center

Zitieren

APA

Martens, T. W., Asche, S. E., JaKa, M. M., Johnson, M. L., Dunnigan, S., Haven, A. L., Morris, C., Barnaby, D., Maciosek, M. V., Dinh, J. M., Kaiser, S. J., Trower, N. K., Gustafson, S. K., Leet, K., Krizka, S. K., Zimmerman, S. H., Castellanos, V. G., Forrester, K. R., & Bergenstal, R. M. (2026). The glucose monitoring comparison in primary care study (GluCoCare): Study design, methods, recruitment success, and baseline characteristics of study participants. Contemporary Clinical Trials, 166, 108357. https://doi.org/10.1016/j.cct.2026.108357

Vancouver

Martens TW, Asche SE, JaKa MM, Johnson ML, Dunnigan S, Haven AL, et al. The glucose monitoring comparison in primary care study (GluCoCare): Study design, methods, recruitment success, and baseline characteristics of study participants. Contemporary Clinical Trials. 2026;166:108357. doi:10.1016/j.cct.2026.108357

BibTeX
@article{Martens2026,
  author = {Martens, Thomas W and Asche, Stephen E and JaKa, Meghan M and Johnson, Mary L and Dunnigan, Sean and Haven, Alyse L and Morris, Colette and Barnaby, David and Maciosek, Michael V and Dinh, Jennifer M and Kaiser, Samantha J and Trower, Nicole K and Gustafson, Sally K and Leet, Kathryn and Krizka, Shannon K and Zimmerman, Stephanie H and Castellanos, Veronika G and Forrester, Kelsea R and Bergenstal, Richard M},
  title = {The glucose monitoring comparison in primary care study (GluCoCare): Study design, methods, recruitment success, and baseline characteristics of study participants},
  journal = {Contemporary Clinical Trials},
  year = {2026},
  volume = {166},
  pages = {108357},
  doi = {10.1016/j.cct.2026.108357}
}
Kostenlos starten →